vs
Side-by-side financial comparison of UNITY BANCORP INC (UNTY) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $35.3M, roughly 1.6× UNITY BANCORP INC). UNITY BANCORP INC runs the higher net margin — 43.9% vs -246.8%, a 290.6% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs 7.6%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-29.5M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 9.8%).
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
UNTY vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.3M | $57.2M |
| Net Profit | $15.5M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 55.8% | -70.5% |
| Net Margin | 43.9% | -246.8% |
| Revenue YoY | 24.2% | 7.6% |
| Net Profit YoY | 34.5% | -2774.3% |
| EPS (diluted) | $1.52 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.3M | $57.2M | ||
| Q3 25 | $32.8M | $56.3M | ||
| Q2 25 | $34.4M | $52.6M | ||
| Q1 25 | $29.4M | $50.0M | ||
| Q4 24 | $28.4M | $53.2M | ||
| Q3 24 | $27.7M | $47.7M | ||
| Q2 24 | $25.5M | $50.5M | ||
| Q1 24 | $25.6M | $47.5M |
| Q4 25 | $15.5M | $-141.2M | ||
| Q3 25 | $14.4M | $-22.6M | ||
| Q2 25 | $16.5M | $-27.2M | ||
| Q1 25 | $11.6M | $-29.5M | ||
| Q4 24 | $11.5M | $-4.9M | ||
| Q3 24 | $10.9M | $-5.3M | ||
| Q2 24 | $9.5M | $-4.5M | ||
| Q1 24 | $9.6M | $-4.1M |
| Q4 25 | 55.8% | -70.5% | ||
| Q3 25 | 57.5% | -55.6% | ||
| Q2 25 | 62.6% | -73.2% | ||
| Q1 25 | 52.6% | -82.0% | ||
| Q4 24 | 51.0% | -19.3% | ||
| Q3 24 | 52.7% | -23.1% | ||
| Q2 24 | 49.3% | -20.1% | ||
| Q1 24 | 50.0% | -19.5% |
| Q4 25 | 43.9% | -246.8% | ||
| Q3 25 | 43.8% | -40.1% | ||
| Q2 25 | 48.0% | -51.7% | ||
| Q1 25 | 39.5% | -58.9% | ||
| Q4 24 | 40.5% | -9.2% | ||
| Q3 24 | 39.4% | -11.2% | ||
| Q2 24 | 37.1% | -9.0% | ||
| Q1 24 | 37.5% | -8.7% |
| Q4 25 | $1.52 | $-2.40 | ||
| Q3 25 | $1.41 | $-0.38 | ||
| Q2 25 | $1.61 | $-0.46 | ||
| Q1 25 | $1.13 | $-0.50 | ||
| Q4 24 | $1.13 | $-0.09 | ||
| Q3 24 | $1.07 | $-0.09 | ||
| Q2 24 | $0.92 | $-0.08 | ||
| Q1 24 | $0.94 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $345.6M | $327.2M |
| Total Assets | $3.0B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $230.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $345.6M | $327.2M | ||
| Q3 25 | $334.0M | $466.0M | ||
| Q2 25 | $319.8M | $486.3M | ||
| Q1 25 | $306.1M | $511.4M | ||
| Q4 24 | $295.6M | $538.5M | ||
| Q3 24 | $284.3M | $541.2M | ||
| Q2 24 | $273.4M | $542.5M | ||
| Q1 24 | $266.8M | $544.0M |
| Q4 25 | $3.0B | $488.9M | ||
| Q3 25 | $2.9B | $601.1M | ||
| Q2 25 | $2.9B | $624.7M | ||
| Q1 25 | $2.8B | $631.9M | ||
| Q4 24 | $2.7B | $656.2M | ||
| Q3 24 | $2.6B | $645.1M | ||
| Q2 24 | $2.6B | $651.4M | ||
| Q1 24 | $2.6B | $652.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.9M | $-29.4M |
| Free Cash FlowOCF − Capex | $44.3M | $-29.5M |
| FCF MarginFCF / Revenue | 125.7% | -51.6% |
| Capex IntensityCapex / Revenue | 1.6% | 0.2% |
| Cash ConversionOCF / Net Profit | 2.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | $81.7M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.9M | $-29.4M | ||
| Q3 25 | $45.5M | $-31.6M | ||
| Q2 25 | $-25.3M | $-15.3M | ||
| Q1 25 | $17.9M | $-33.1M | ||
| Q4 24 | $48.0M | $-1.8M | ||
| Q3 24 | $17.7M | $-14.6M | ||
| Q2 24 | $-8.4M | $-6.9M | ||
| Q1 24 | $15.8M | $7.6M |
| Q4 25 | $44.3M | $-29.5M | ||
| Q3 25 | $45.3M | $-31.8M | ||
| Q2 25 | $-25.5M | $-15.6M | ||
| Q1 25 | $17.6M | $-33.6M | ||
| Q4 24 | $47.3M | $-2.0M | ||
| Q3 24 | $17.5M | $-14.7M | ||
| Q2 24 | $-8.6M | $-7.0M | ||
| Q1 24 | $15.7M | $7.6M |
| Q4 25 | 125.7% | -51.6% | ||
| Q3 25 | 138.1% | -56.5% | ||
| Q2 25 | -74.2% | -29.6% | ||
| Q1 25 | 59.9% | -67.1% | ||
| Q4 24 | 166.5% | -3.8% | ||
| Q3 24 | 63.3% | -30.9% | ||
| Q2 24 | -33.7% | -13.9% | ||
| Q1 24 | 61.4% | 15.9% |
| Q4 25 | 1.6% | 0.2% | ||
| Q3 25 | 0.7% | 0.3% | ||
| Q2 25 | 0.5% | 0.6% | ||
| Q1 25 | 1.0% | 0.9% | ||
| Q4 24 | 2.4% | 0.4% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 0.5% | 0.2% | ||
| Q1 24 | 0.3% | 0.0% |
| Q4 25 | 2.90× | — | ||
| Q3 25 | 3.16× | — | ||
| Q2 25 | -1.54× | — | ||
| Q1 25 | 1.54× | — | ||
| Q4 24 | 4.17× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | -0.89× | — | ||
| Q1 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
UNTY
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
